Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04427449 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT04427449 · ClinicalTrials.gov record · last posted 2026-08-24

4SCAR-CD44v6 T Cell Therapy Targeting Cancer

Name: 4SCAR-CD44v6 T Cell Therapy Targeting Cancer — clinical trial record (NCT04427449)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusTerminated

PhasePhase 1/2

SponsorShenzhen Geno-Immune Medical Institute

Started2026-06-01

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The purpose of this clinical trial is to assess the feasibility, safety and efficacy of 4SCAR-CD44v6 T-cell therapy targeting multiple cancers. The study also aims to learn more about the function of the CD44v6 CAR-T cells and their persistency in the patients.

Protocol amendment history 3 changes detected by DataLookout

2026-08-25

Trial terminated

2026-08-25

Primary completion moved earlier: 2029-12-31 → 2026-07-01

2026-08-25

Completion moved earlier: 2030-12-31 → 2026-07-31

Trial Details

NCT Number	NCT04427449
Lead Sponsor	Shenzhen Geno-Immune Medical Institute
Conditions	Cancers Which Are CD44v6 Positive
Enrollment	100 participants
Start Date	2026-06-01
Primary Completion	2026-07-01 (estimated)
Study Completion	2026-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-24